Status:
COMPLETED
Mental Perfomance in Patients With Coeliac Disease
Lead Sponsor:
University Children's Hospital Basel
Conditions:
Celiac Disease in Children
Gluten Allergy
Eligibility:
All Genders
4-18 years
Brief Summary
Coeliac disease (CD) is an immune-mediated systemic disorder triggered by gluten in genetically predisposed patients. The only available treatment is a strict life long gluten-free diet (GFD), which h...
Detailed Description
Between July 2020 and August 2021, all children aged between 6 and 18 years, under the care of the University Children's hospital of Basel and the Children's hospital of Aarau, Switzerland, diagnosed ...
Eligibility Criteria
Inclusion
- CD diagnosed according to European guidelines (ESPGHAN)
- only patients, who stick to a strict glutenfree diet (measured by transglutaminase for at least a year before participation in the study)
Exclusion
- any other chronic disease
- \-
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
444 Patients enrolled
Trial Details
Trial ID
NCT06519916
Start Date
July 1 2020
End Date
August 1 2021
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's HOspital
Basel, Switzerland